ABCG2 and escherichia coli infection: Level 3 predicted functional pathways significantly changed across treatments (ANOVA P ≤ 0.05), including biosynthesis of ansamycins, bacterial invasion of epithelial cells, pathogenic E. coli infection, ABC transporters, and glutathione metabolism in alignment with other results herein.